Amphiregulin

Amphiregulin

Amphiregulin 詳細

Molecule Name
Amphiregulin
分子の別称
AR, AREGB, CRDGF, SDGF
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 1 Clinical
ターゲットの別称
AREGB,Colorectum cell-derived growth factor,AR,Schwannoma-Derived Growth Factor,Amphiregulin B,CRDGF,SDGF,SDGF GN
バックグランド
Amphiregulin (AREG), which acts as one of the ligands for epidermal receptor growth factor receptor (EGFR), plays a crucial role in tissue repair, inflammation, and immunity. It is an autocrine growth factor as well as a mitogen for astrocytes, Schwann cells and fibroblasts. It is related to epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). The protein interacts with the EGF/TGF-alpha receptor to promote the growth of normal epithelial cells, and it inhibits the growth of certain aggressive carcinoma cell lines. It also functions in mammary gland, oocyte and bone tissue development. This gene is associated with a psoriasis-like skin phenotype, and is also associated with other pathological disorders, including various types of cancers and inflammatory conditions. [provided by RefSeq, Apr 2014]

Amphiregulin 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
SRN-001SRN-001Phase 1 ClinicalsiRNAgen Therapeutics Inc
Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis; Chronic Kidney Disease-Mineral and Bone Disorder
詳細
PMG-1015PMG-1015Phase 1 ClinicalPulmongene Ltd
Idiopathic Pulmonary Fibrosis
詳細